USA's 'Obamacare' is not what the doctor ordered, claims new book
US President Barack Obama's national health care mandate will undoubtedly lead to the largest expansion of government in the history of the USA and will cost taxpayers at least $1,000 billion over 10 years. 'And that's just the beginning, says Sally Pipes, author of The Truth About Obamacare, in a posting on the web site of the think tank Pacific Research Institute.
As candidates across the country debate and defend their stance on health care, Ms Pipes dissects the 2,400-page bill, exposing the most wasteful, inefficient, and dangerous provisions that will irrevocably hurt the USA's health care system and its economy.
Obama promised a minor miracle
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze